Congress clears legal path for fentanyl-detection tools in overdose fight
H.R. 1563 — STOP Fentanyl and Xylazine Act · Filed by Jasmine Crockett (D-TX) · 1 cosponsor · Introduced Feb 25, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends the Controlled Substances Act to explicitly permit the possession, sale, purchase, import, export, and transport of drug testing equipment designed to detect fentanyl or xylazine. Currently, such equipment may be treated as drug paraphernalia under federal law; this bill clarifies that testing equipment for these two substances is not unlawful, enabling harm-reduction programs and individuals to access fentanyl/xylazine detection tools without federal criminal exposure.
Why we flagged it
The bill's sole operative mechanism is to decriminalize a specific class of drug-testing equipment in service of overdose prevention. It is a narrow, targeted public-health measure with no private carve-outs or industry giveaways.
What the text implies
- Clarification applies only to fentanyl and xylazine detection; other drug-testing equipment (e.g., for cocaine, methamphetamine) remains subject to existing paraphernalia restrictions, potentially creating a two-tier legal regime.
- The bill does not fund distribution or subsidize testing equipment; it only removes the federal criminal barrier. Actual access depends on state law, local policy, and nonprofit/public-health funding.
- Exemption is limited to equipment whose 'intended use' is detection; enforcement may turn on proof of intent, creating potential ambiguity in borderline cases.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Ordinary people—especially those in communities affected by opioid overdose—gain access to low-cost, non-invasive detection tools that can prevent fatal overdoses. Harm-reduction organizations can operate without federal criminal liability. The bill removes a legal barrier without imposing new costs or restrictions on citizens.
Named in the bill
Controlled Substances Act, Section 422 (CSA), fentanyl, xylazine, drug testing equipment, harm-reduction organizations
Where it stands
1 cosponsor: 1 Republicans.
- Feb 25, 2025 — Introduced · Congress.gov: “Introduced in House”
- Feb 25, 2025 — Referred to House Committee on Energy and Commerce and House Committee on the Judiciary · Congress.gov: “Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (605 characters) on Oct 31, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,778 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-31.
“Congress clears legal path for fentanyl-detection tools in overdose fight” QuorumCivic. https://share.quorumcivic.app/bill/119/hr1563 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.